The company provides diagnostic solutions for serious infections in US, Europe, and Middle East. It offers the Accelerate Pheno system for identifying pathogens and antibiotic susceptibility testing. The platform targets gram-positive and gram-negative organisms associated with serious infections. The company also provides the Accelerate PhenoTest kit for identity and antibiotic susceptibility testing. This test is used to diagnose bacteremia or fungemia, life-threatening conditions. The company was formerly known as Accelr8 Technology Corporation before changing its name in 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Indicator | Value |
---|---|
PER | 100.0 |
EV/EBITDA | 100.0 |
Price/Free Cash Flow' | 100.0 |
ROIC | -% |
Net Debt/EBITDA | 100.0 |